Institut de Science des Matériaux de Mulhouse, Université de Haute-Alsace, CNRS/UHA UMR 7361, Mulhouse, France.
Polymer for Health and Biomaterials, IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.
Colloids Surf B Biointerfaces. 2024 Sep;241:114039. doi: 10.1016/j.colsurfb.2024.114039. Epub 2024 Jun 13.
Thin films have been identified as an alternative approach for targeting sensitive site as drug delivery tool. In this work, the preparation of self-rolling thin films to form tubes for wound healing and easy placement (e.g. in the colon via colonoscopy) have been studied. We explored the use of thin films as a protective dressing combined to local release of an anti-inflammatory in order to improve drug efficacy and limit the side effects of the oral route. Non-cytotoxic poly(ethylene) glycol and poly(lactic acid) photo-crosslinkable star copolymers were used for rapid UV crosslinking of bilayered films loaded with prednisolone. The films, crosslinked under UV lamp without the need of photoinitiator, are optimized and compared in terms of water uptake, swelling ratio, final tube diameter and morphology, anti-inflammatory drug loading and release. Our studies showed the spontaneous rolling of bilayer constructs directly after immersion in water. Tubular geometry allows application of the patch through minimally invasive procedures such as colonoscopy. Moreover, the rolled-up bilayers highlighted efficient release of encapsulated drug following Fickian diffusion mechanism. We also confirmed the anti-inflammatory activity of the released anti-inflammatory drug that inhibits the pro-inflammatory cytokine IL-1β in RAW 264.7 macrophages stimulated by Escherichia coli (E. coli).
薄膜已被确定为一种替代方法,可用于将敏感部位作为药物输送工具。在这项工作中,研究了制备自卷薄膜以形成用于伤口愈合和易于放置(例如通过结肠镜检查放置在结肠中)的管状结构。我们探索了将薄膜用作保护敷料与局部释放抗炎药相结合的方法,以提高药物疗效并限制口服途径的副作用。使用非细胞毒性聚乙二醇和聚(乳酸)光交联星型共聚物来快速紫外线交联载有泼尼松龙的双层薄膜。这些薄膜在没有光引发剂的情况下通过紫外灯交联,可以根据水吸收、溶胀比、最终管直径和形态、抗炎药物负载和释放对其进行优化和比较。我们的研究表明,双层结构在浸入水中后会自发地卷成管状。管状结构允许通过微创程序(例如结肠镜检查)应用贴片。此外,卷起的双层结构突出显示了封装药物的有效释放,该释放遵循 Fickian 扩散机制。我们还证实了释放的抗炎药物具有抗炎活性,该药物可抑制大肠杆菌(E. coli)刺激的 RAW 264.7 巨噬细胞中促炎细胞因子 IL-1β的产生。